Login to Your Account

The European Society of Cardiology

Look out, Effient: Brilinta, Plavix Data Wow at Cardiology Meeting

By Jennifer Boggs

Tuesday, September 1, 2009
The European Society of Cardiology meeting kicked off in Barcelona over with weekend with better-than-expected data in the antiplatelet space from blockbuster Plavix (clopidogrel) and late-stage candidate Brilinta (ticagrelor), though the latest news struck another blow to Effient (prasurgrel), a recently approved blood thinner from Eli Lilly and Co. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription